HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Nakagawa Selected Research

5- hydroxy- 6- (2- keto- 3- thiopropionyl)- 7,9,11,14- eicosatetraenoic acid

6/2001Early relapse after high-dose chemotherapy rescued by tumor-free autologous peripheral blood stem cells in acute lymphoblastic leukemia: importance of monitoring for WT1-mRNA quantitatively.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Nakagawa Research Topics

Disease

26Neoplasms (Cancer)
07/2015 - 01/2000
7Urinary Bladder Neoplasms (Bladder Cancer)
01/2016 - 07/2000
7Infections
02/2012 - 01/2000
6Lymphoma (Lymphomas)
03/2015 - 06/2000
6Neoplasm Metastasis (Metastasis)
07/2014 - 07/2000
5Carcinogenesis
03/2015 - 01/2012
5Leukemia
03/2015 - 02/2001
5Stomach Neoplasms (Stomach Cancer)
10/2014 - 11/2000
5Hypertension (High Blood Pressure)
01/2013 - 04/2000
4Squamous Cell Carcinoma of Head and Neck
03/2015 - 04/2013
4Lymphatic Metastasis
06/2008 - 05/2001
4Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy)
08/2004 - 01/2001
4Bone Resorption
10/2000 - 05/2000
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2014 - 08/2000
3Alexander Disease (Alexander's Disease)
08/2011 - 10/2004
3Parkinsonian Disorders (Parkinsonism)
11/2010 - 07/2001
3Insulin Resistance
07/2006 - 06/2001
3Lung Neoplasms (Lung Cancer)
01/2005 - 02/2000
3Atrophy
10/2004 - 04/2000
3Colonic Neoplasms (Colon Cancer)
12/2001 - 05/2001
3Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2001 - 06/2000
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2001 - 02/2001
3Ischemia
09/2001 - 07/2001
2Nausea
04/2015 - 11/2001
2Vomiting
04/2015 - 11/2001
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2013 - 09/2011
2Alzheimer Disease (Alzheimer's Disease)
02/2013 - 11/2010
2Edema (Dropsy)
08/2012 - 04/2003
2Hematologic Neoplasms (Hematological Malignancy)
02/2012 - 02/2005
2Tuberculosis (Tuberculoses)
03/2011 - 10/2001
2Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
11/2010 - 01/2001
2Unstable Angina
11/2010 - 12/2007
2Adenocarcinoma
01/2010 - 02/2000
2Polyps
01/2010 - 08/2001
2Inflammation (Inflammations)
12/2007 - 06/2001
2Renal Insufficiency (Renal Failure)
03/2007 - 04/2005
2Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
02/2007 - 06/2006
2Carcinoma (Carcinomatosis)
09/2005 - 09/2001
2Hyperparathyroidism
04/2005 - 08/2001
2Respiratory Insufficiency (Respiratory Failure)
04/2005 - 04/2000
2Mitochondrial Myopathies (Mitochondrial Myopathy)
10/2004 - 07/2000
2Dementia (Dementias)
10/2004 - 07/2001
2Graft vs Host Disease (Graft-Versus-Host Disease)
03/2004 - 12/2002
2Liver Diseases (Liver Disease)
09/2003 - 12/2001
2Miyoshi myopathy
06/2003 - 02/2001
2Colorectal Neoplasms (Colorectal Cancer)
12/2001 - 02/2001
2Candidemia
11/2001 - 07/2001
2B-Cell Lymphoma (Lymphoma, B Cell)
11/2001 - 02/2001
2Acute Lung Injury
11/2001 - 07/2001
2Anemia
09/2001 - 01/2000
2Heart Failure
07/2001 - 06/2001

Drug/Important Bio-Agent (IBA)

10MicroRNAs (MicroRNA)IBA
01/2016 - 03/2010
8Proteins (Proteins, Gene)FDA Link
11/2010 - 05/2000
7Messenger RNA (mRNA)IBA
07/2001 - 03/2000
6Pharmaceutical PreparationsIBA
02/2012 - 01/2000
6AntigensIBA
01/2011 - 01/2000
4Etoposide (VP 16)FDA LinkGeneric
09/2001 - 10/2000
3Laminin (Merosin)IBA
11/2013 - 02/2000
3Glial Fibrillary Acidic ProteinIBA
08/2011 - 10/2004
3AntibodiesIBA
02/2005 - 07/2001
3Fluorouracil (Carac)FDA LinkGeneric
01/2005 - 05/2001
3Mitochondrial DNA (mtDNA)IBA
10/2004 - 07/2000
3Cyclosporine (Ciclosporin)FDA LinkGeneric
03/2004 - 09/2001
3titanium silicide (TS-1)IBA
12/2001 - 11/2001
3Fatty Acids (Saturated Fatty Acids)IBA
11/2001 - 06/2001
3Retinaldehyde (Retinal)IBA
09/2001 - 10/2000
3Fibrinogen (Factor I)FDA Link
05/2001 - 01/2000
3Interleukin-6 (Interleukin 6)IBA
04/2001 - 01/2000
2CollagenIBA
10/2015 - 05/2001
2mouse MIRN874 microRNAIBA
04/2013 - 09/2011
2Cell Wall SkeletonIBA
08/2012 - 06/2008
2Anti-Bacterial Agents (Antibiotics)IBA
02/2012 - 01/2000
2Proton Pump InhibitorsIBA
01/2010 - 04/2009
2Biological ProductsIBA
09/2009 - 10/2000
2AlbuminsIBA
09/2008 - 01/2000
2InterferonsIBA
10/2006 - 08/2000
2Insulin (Novolin)FDA Link
07/2006 - 06/2001
2Intravenous Immunoglobulins (IVIG)FDA Link
04/2005 - 03/2000
2Immunoglobulin G (IgG)IBA
02/2005 - 10/2001
2Nonsense Codon (Nonsense Mutation)IBA
08/2004 - 02/2001
2Levodopa (L Dopa)FDA LinkGeneric
09/2003 - 07/2001
2DysferlinIBA
06/2003 - 02/2001
2Dihydrotachysterol (AT 10)IBA
02/2003 - 09/2001
2ConnexinsIBA
01/2003 - 01/2001
2Tumor Viral Antigens (Large T Antigen)IBA
11/2001 - 06/2000
2EnzymesIBA
10/2001 - 10/2000
2CalpainIBA
09/2001 - 05/2000
2Glutamic Acid (Glutamate)FDA Link
09/2001 - 07/2001
2Trihexyphenidyl (Artane)FDA LinkGeneric
07/2001 - 04/2000

Therapy/Procedure

15Therapeutics
08/2012 - 01/2000
6Drug Therapy (Chemotherapy)
10/2014 - 06/2000
4Aftercare (After-Treatment)
02/2007 - 04/2000
3Immunotherapy
08/2012 - 02/2005
3Transplantation
03/2011 - 06/2001
3Catheter Ablation
07/2000 - 01/2000
2Gastrectomy
10/2014 - 11/2001
2Kidney Transplantation
01/2012 - 04/2005
2Adjuvant Chemotherapy
01/2005 - 11/2001
2Hematopoietic Stem Cell Transplantation
12/2003 - 12/2002
2Lymph Node Excision (Lymph Node Dissection)
11/2001 - 01/2001